PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31744501 ↗2019Reported benefit

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators.

MouseChemical/toxinICR (specific pathogen-free)Malen = 70 male ICR mice randomly divided into seven groups; per-gr…Intravenous (doxorubicin given intraperitoneally)0.5 g/kg (low), 1.5 g/kg (medium) or 5 g/kg (high); Shenmai…Pretreatment groups received Shenmai within 24 h before the first doxorubicin a…

Model: Acute cardiotoxicity induced by a cumulative intraperitoneal dose of doxorubicin 10 mg/kg given on the third experimental day, dissolved in 0.9% saline

Doxorubicin reduced heart rate, cardiac output, ejection fraction and fractional shortening, raised serum AST and LDH, increased IL-6, MCP-1, IFN-gamma and TNF, raised IKK-alpha and iNOS expression and serum nitric oxide, increased cardiac nitrotyrosine and produced myofibrillar disarrangement and…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.